Biodexa Pharmaceuticals (BDRX) EPS (Basic) (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) reported EPS (Basic) of -$0.05 for Q2 2025, down 58.3% sequentially from -$0.03 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) EPS (Basic) (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 13 years of EPS (Basic) data on file, last reported at -$0.05 in Q2 2025.
- For the quarter ending Q2 2025, EPS (Basic) changed N/A year-over-year to -$0.05; the trailing twelve-month figure through Dec 2025 stood at -$0.0 (up 99.56% YoY), and the FY2025 full-year result was -$0.0, up 97.55% from the prior year.
- EPS (Basic) eased to -$0.05 in Q2 2025, from -$0.03 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.02 in Q4 2022 to a low of -$0.06 in Q4 2023.
- A 5-year average of -$0.04 and a median of -$0.03 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 90.13% in 2021 and plunged 224.08% in 2023, its largest moves.
- Tracing BDRX's EPS (Basic) over 5 years: stood at -$0.03 in 2021, then surged by 31.23% to -$0.02 in 2022, then sank by 224.08% to -$0.06 in 2023, then soared by 44.92% to -$0.03 in 2024, then tumbled by 58.3% to -$0.05 in 2025.
- Business Quant data shows BDRX's EPS (Basic) at -$0.05 in Q2 2025, -$0.03 in Q4 2024, and -$0.06 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.05 |
| Dec 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.06 |
| Jun 30, 2023 | -0.02 |
| Dec 31, 2022 | -0.02 |
| Sep 14, 2022 | -0.02 |
| Dec 31, 2021 | -0.03 |
| Sep 17, 2021 | -0.05 |
| Dec 31, 2020 | -0.27 |
| Sep 10, 2020 | -0.03 |
| Dec 31, 2019 | 0.00 |
| Dec 31, 2018 | -0.04 |
| Dec 31, 2017 | -0.05 |
| Dec 31, 2016 | 0.00 |
| Dec 31, 2015 | -0.01 |
| Dec 31, 2014 | 0.00 |
| Dec 31, 2013 | 0.00 |